MedTrace Logo

Italian Non-Interventional Study of FLT3 Mutated AML Patients

NCT03547258 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2020-04-21

No results posted yet for this study

Summary

This is an observational study involving a retrospective and prospective collection of clinical and molecular data regarding patients with AML with FLT3+ mutations

Conditions

  • AML
  • FLT3-ITD Mutation
  • FLT3-TKD Mutation

Interventions

GENETIC

Clinical and Molecular data collection

Clinical and Molecular data collection at diagnosis, during treatment and at each relapse

Sponsors & Collaborators

  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

    lead OTHER

Principal Investigators

  • Giovanni Martinelli, MD · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-18
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03547258 on ClinicalTrials.gov